Sign in
NSPR Stock Price, Chart, Stats & News
InspireMD, Inc.
Save
32.79M
Market cap
–
Current P/E
11.70x
Forward P/E
NSPR chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 29.50% |
Operating margin | -546.97% |
Pretax margin | -542.63% |
Net margin | -543.33% |
Effective tax rate | -0.13% |
ROA | -70.29% |
ROE | -116.22% |
D/E | 0.04x |
Interest coverage ratio | -372.06x |
NSPR valuation
P/E | – |
P/S | 7.50x |
P/B | 2.12x |
P/CF | -3.33x |
P/FCF | -1.83x |
P/OCF | -3.33x |
PEG | -0.40x |
EV multiple | -1.52x |
About
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific.
Similar securities
Based on sector and market capitalization
Report issue